{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T20:37:22Z","timestamp":1790455042911,"version":"4.1.0"},"reference-count":43,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":97,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Rheum Dis"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1111\/1756-185x.12607","type":"journal-article","created":{"date-parts":[[2015,5,27]],"date-time":"2015-05-27T16:41:49Z","timestamp":1432744909000},"page":"606-615","source":"Crossref","is-referenced-by-count":14,"title":["Financial conflicts of interest and their association with outcome and quality of fibromyalgia drug therapy randomized controlled trials"],"prefix":"10.1111","volume":"18","author":[{"given":"Winnie K.","family":"Pang","sequence":"first","affiliation":[{"name":"University of Southern California-Los Angeles County Medical Center; Los Angeles CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen C.","family":"Yeter","sequence":"additional","affiliation":[{"name":"University of Southern California-Los Angeles County Medical Center; Los Angeles CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina D.","family":"Torralba","sequence":"additional","affiliation":[{"name":"Loma Linda University; Loma Linda CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horace J.","family":"Spencer","sequence":"additional","affiliation":[{"name":"University of Arkansas for Medical Sciences; Little Rock AR USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasim A.","family":"Khan","sequence":"additional","affiliation":[{"name":"Central Arkansas Veterans Healthcare System; University of Arkansas for Medical Sciences; Little Rock AR USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,5,27]]},"reference":[{"key":"10.1111\/1756-185X.12607-BIB0001|apl12607-cit-0001","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1136\/ard.2007.071522","article-title":"EULAR evidence-based recommendations for the management of fibromyalgia syndrome","volume":"67","author":"Carville","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/1756-185X.12607-BIB0002|apl12607-cit-0002","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/01.rhu.0000221817.46231.18","article-title":"The incidence of fibromyalgia and its associated comorbidities: a population-based retrospective cohort study based on International Classification of Diseases, 9th Revision codes","volume":"12","author":"Weir","year":"2006","journal-title":"J Clin Rheumatol"},{"key":"10.1111\/1756-185X.12607-BIB0003|apl12607-cit-0003","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.rdc.2009.05.009","article-title":"Clinical manifestations and diagnosis of fibromyalgia","volume":"35","author":"Bennett","year":"2009","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1111\/1756-185X.12607-BIB0004|apl12607-cit-0004","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/art.23176","article-title":"Estimates of the prevalence of arthritis and other rheumatic conditions in the United States","volume":"58","author":"Lawrence","year":"2008","journal-title":"Part II. Arthritis Rheum"},{"key":"10.1111\/1756-185X.12607-BIB0005|apl12607-cit-0005","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/1471-2474-12-224","article-title":"Prevalence of fibromyalgia in France: a multi-step study research combining national screening and clinical confirmation: The DEFI study (Determination of Epidemiology of FIbromyalgia)","volume":"12","author":"Perrot","year":"2011","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1111\/1756-185X.12607-BIB0006|apl12607-cit-0006","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/acr.21931","article-title":"Fibromyalgia prevalence, somatic symptom reporting, and the dimensionality of polysymptomatic distress: results from a survey of the general population","volume":"65","author":"Wolfe","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1111\/1756-185X.12607-BIB0007|apl12607-cit-0007","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1001\/jama.289.4.454","article-title":"Scope and impact of financial conflicts of interest in biomedical research: a systematic review","volume":"289","author":"Bekelman","year":"2003","journal-title":"JAMA"},{"key":"10.1111\/1756-185X.12607-BIB0008|apl12607-cit-0008","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1345\/aph.1D267","article-title":"Industry sponsorship and authorship of clinical trials over 20\u00a0years","volume":"38","author":"Buchkowsky","year":"2004","journal-title":"Ann Pharmacother"},{"key":"10.1111\/1756-185X.12607-BIB0009|apl12607-cit-0009","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1136\/bmj.38768.420139.80","article-title":"Origin and funding of the most frequently cited papers in medicine: database analysis","volume":"332","author":"Patsopoulos","year":"2006","journal-title":"BMJ"},{"key":"10.1111\/1756-185X.12607-BIB0010|apl12607-cit-0010","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1001\/jama.294.1.110","article-title":"Reporting conflicts of interest, financial aspects of research, and role of sponsors in funded studies","volume":"294","author":"Fontanarosa","year":"2005","journal-title":"JAMA"},{"key":"10.1111\/1756-185X.12607-BIB0011|apl12607-cit-0011","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1136\/ard.59.6.414","article-title":"Epidemiology of research into interventions for the treatment of osteoarthritis of the knee joint","volume":"59","author":"Chard","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/1756-185X.12607-BIB0012|apl12607-cit-0012","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/fampra\/18.6.565","article-title":"The association between funding by commercial interests and study outcome in randomized controlled drug trials","volume":"18","author":"Yaphe","year":"2001","journal-title":"Fam Pract"},{"key":"10.1111\/1756-185X.12607-BIB0013|apl12607-cit-0013","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1001\/jama.290.7.921","article-title":"Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events?","volume":"290","author":"Als-Nielsen","year":"2003","journal-title":"JAMA"},{"key":"10.1111\/1756-185X.12607-BIB0014|apl12607-cit-0014","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1136\/bmj.326.7400.1167","article-title":"Pharmaceutical industry sponsorship and research outcome and quality: systematic review","volume":"326","author":"Lexchin","year":"2003","journal-title":"BMJ"},{"key":"10.1111\/1756-185X.12607-BIB0015|apl12607-cit-0015","first-page":"477","article-title":"Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials","volume":"170","author":"Bhandari","year":"2004","journal-title":"CMAJ"},{"key":"10.1111\/1756-185X.12607-BIB0016|apl12607-cit-0016","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.cct.2004.09.002","article-title":"An analysis of the effect of funding source in randomized clinical trials of second generation antipsychotics for the treatment of schizophrenia","volume":"25","author":"Montgomery","year":"2004","journal-title":"Control Clin Trials"},{"key":"10.1111\/1756-185X.12607-BIB0017|apl12607-cit-0017","doi-asserted-by":"crossref","first-page":"158","DOI":"10.7326\/0003-4819-153-3-201008030-00006","article-title":"Outcome reporting among drug trials registered in ClinicalTrials.gov","volume":"153","author":"Bourgeois","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1111\/1756-185X.12607-BIB0018|apl12607-cit-0018","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1371\/journal.pmed.0020124","article-title":"Why most published research findings are false","volume":"2","author":"Ioannidis","year":"2005","journal-title":"PLoS Med"},{"key":"10.1111\/1756-185X.12607-BIB0019|apl12607-cit-0019","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1056\/NEJM198312013092204","article-title":"Bias in treatment assignment in controlled clinical trials","volume":"309","author":"Chalmers","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1111\/1756-185X.12607-BIB0020|apl12607-cit-0020","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/sim.4780080408","article-title":"How study design affects outcomes in comparisons of therapy. I: Medical","volume":"8","author":"Colditz","year":"1989","journal-title":"Stat Med"},{"key":"10.1111\/1756-185X.12607-BIB0021|apl12607-cit-0021","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?","volume":"352","author":"Moher","year":"1998","journal-title":"Lancet"},{"key":"10.1111\/1756-185X.12607-BIB0022|apl12607-cit-0022","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/art.512","article-title":"Secular changes in the quality of published randomized clinical trials in rheumatology","volume":"46","author":"Hill","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1111\/1756-185X.12607-BIB0023|apl12607-cit-0023","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1002\/art.34393","article-title":"Association of industry funding with the outcome and quality of randomized controlled trials of drug therapy for rheumatoid arthritis","volume":"64","author":"Khan","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1111\/1756-185X.12607-BIB0024|apl12607-cit-0024","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/j.1537-2995.2006.00854.x","article-title":"Which patients to include in the analysis?","volume":"46","author":"Kunz","year":"2005","journal-title":"Transfusion"},{"key":"10.1111\/1756-185X.12607-BIB0025|apl12607-cit-0025","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0140-6736(05)71879-1","article-title":"Epidemiology and reporting of randomised trials published in PubMed journals","volume":"365","author":"Chan","year":"2005","journal-title":"Lancet"},{"key":"10.1111\/1756-185X.12607-BIB0026|apl12607-cit-0026","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1213\/01.ANE.0000150612.71007.A3","article-title":"The quality of randomized controlled trials in major anesthesiology journals","volume":"100","author":"Greenfield","year":"2005","journal-title":"Anesth Analg"},{"key":"10.1111\/1756-185X.12607-BIB0027|apl12607-cit-0027","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.2337\/dc06-0077","article-title":"Systematic evaluation of the quality of randomized controlled trials in diabetes","volume":"29","author":"Montori","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1111\/1756-185X.12607-BIB0028|apl12607-cit-0028","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/rheumatology\/ken230","article-title":"Learning from past mistakes: assessing trial quality, power and eligibility in non-renal systemic lupus erythematosus randomized controlled trials","volume":"47","author":"Yuen","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1111\/1756-185X.12607-BIB0029|apl12607-cit-0029","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1136\/bmj.313.7057.570","article-title":"Better reporting of randomised controlled trials: the CONSORT statement","volume":"313","author":"Altman","year":"1996","journal-title":"BMJ"},{"key":"10.1111\/1756-185X.12607-BIB0030|apl12607-cit-0030","doi-asserted-by":"crossref","first-page":"663","DOI":"10.7326\/0003-4819-134-8-200104170-00012","article-title":"The revised CONSORT statement for reporting randomized trials: explanation and elaboration","volume":"134","author":"Altman","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1111\/1756-185X.12607-BIB0031|apl12607-cit-0031","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jclinepi.2010.03.004","article-title":"CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials","volume":"63","author":"Moher","year":"2010","journal-title":"J Clin Epidemiol"},{"key":"10.1111\/1756-185X.12607-BIB0032|apl12607-cit-0032","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1001\/jama.285.15.1992","article-title":"Use of the CONSORT statement and quality of reports of randomized trials: a comparative before-and-after evaluation","volume":"285","author":"Moher","year":"2001","journal-title":"JAMA"},{"key":"10.1111\/1756-185X.12607-BIB0033|apl12607-cit-0033","doi-asserted-by":"crossref","first-page":"263","DOI":"10.5694\/j.1326-5377.2006.tb00557.x","article-title":"Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review","volume":"185","author":"Plint","year":"2006","journal-title":"Med J Aust"},{"key":"10.1111\/1756-185X.12607-BIB0034|apl12607-cit-0034","doi-asserted-by":"crossref","first-page":"c723","DOI":"10.1136\/bmj.c723","article-title":"The quality of reports of randomised trials in 2000 and 2006: comparative study of articles indexed in PubMed","volume":"340","author":"Hopewell","year":"2010","journal-title":"BMJ"},{"key":"10.1111\/1756-185X.12607-BIB0035|apl12607-cit-0035","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1136\/bmj.38413.576713.AE","article-title":"Adequacy and reporting of allocation concealment: review of recent trials published in four general medical journals","volume":"330","author":"Hewitt","year":"2005","journal-title":"BMJ"},{"key":"10.1111\/1756-185X.12607-BIB0036|apl12607-cit-0036","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.cct.2005.02.008","article-title":"The quality of randomized trial reporting in leading medical journals since the revised CONSORT statement","volume":"26","author":"Mills","year":"2005","journal-title":"Contemp Clin Trials"},{"key":"10.1111\/1756-185X.12607-BIB0037|apl12607-cit-0037","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1001\/jama.290.8.1062","article-title":"Methodological differences in clinical trials evaluating\u00a0nonpharmacological and pharmacological treatments of hip and knee osteoarthritis","volume":"290","author":"Boutron","year":"2003","journal-title":"JAMA"},{"key":"10.1111\/1756-185X.12607-BIB0038|apl12607-cit-0038","doi-asserted-by":"crossref","first-page":"e1000144","DOI":"10.1371\/journal.pmed.1000144","article-title":"Trial publication after registration in ClinicalTrials.Gov: a cross-sectional analysis","volume":"6","author":"Ross","year":"2009","journal-title":"PLoS Med"},{"key":"10.1111\/1756-185X.12607-BIB0039|apl12607-cit-0039","doi-asserted-by":"crossref","first-page":"d7292","DOI":"10.1136\/bmj.d7292","article-title":"Publication of NIH funded trials registered in ClinicalTrials.gov: cross sectional analysis","volume":"344","author":"Ross","year":"2012","journal-title":"BMJ"},{"key":"10.1111\/1756-185X.12607-BIB0040|apl12607-cit-0040","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1001\/jama.2009.1242","article-title":"Comparison of registered and published primary outcomes in randomized controlled trials","volume":"302","author":"Mathieu","year":"2009","journal-title":"JAMA"},{"key":"10.1111\/1756-185X.12607-BIB0041|apl12607-cit-0041","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(00)02605-2","article-title":"The uncertainty principle and industry-sponsored research","volume":"356","author":"Djulbegovic","year":"2000","journal-title":"Lancet"},{"key":"10.1111\/1756-185X.12607-BIB0042|apl12607-cit-0042","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/S0895-4356(02)00440-7","article-title":"Discrepancy between published report and actual conduct of randomized clinical trials","volume":"55","author":"Hill","year":"2002","journal-title":"J Clin Epidemiol"},{"key":"10.1111\/1756-185X.12607-BIB0043|apl12607-cit-0043","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.jclinepi.2004.03.017","article-title":"An observational study found that authors of randomized controlled trials frequently use concealment of randomization and blinding, despite the failure to report these methods","volume":"57","author":"Devereaux","year":"2004","journal-title":"J Clin Epidemiol"}],"container-title":["International Journal of Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2F1756-185X.12607","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/1756-185X.12607\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T14:42:14Z","timestamp":1625496134000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/1756-185X.12607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,27]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,7]]}},"URL":"https:\/\/doi.org\/10.1111\/1756-185x.12607","relation":{},"ISSN":["1756-1841"],"issn-type":[{"value":"1756-1841","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5,27]]}}}